EDGAR Filing Documents for 0001104659-23-068331

Form 8-K - Current report:

SEC Accession No. 0001104659-23-068331

Filing Date

2023-06-06

Accepted

2023-06-06 08:00:13

Documents

Period of Report

2023-06-02

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2317750d1_8k.htm iXBRL	8-K	61144
2	EXHIBIT 3.1	tm2317750d1_ex3-1.htm	EX-3.1	132211
3	EXHIBIT 3.2	tm2317750d1_ex3-2.htm	EX-3.2	170383
	Complete submission text file	0001104659-23-068331.txt		608810

Data Files

Seq	Description	Document	Type	Size
4	XBRL TAXONOMY EXTENSION SCHEMA	atxs-20230602.xsd	EX-101.SCH	3036
5	XBRL TAXONOMY EXTENSION LABEL LINKBASE	atxs-20230602_lab.xml	EX-101.LAB	34476
6	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	atxs-20230602_pre.xml	EX-101.PRE	22597
8	EXTRACTED XBRL INSTANCE DOCUMENT	tm2317750d1_8k_htm.xml	XML	3724

Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109

Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971

Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)